Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment Effects and Relation to Coronary Angiographic Progression

Open access
Mack, Wendy J., Krauss, Ronald M., Hodis, Howard N. · 1996 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Abstract Accumulating evidence suggests that triglyceride-rich lipoproteins contribute to coronary artery disease. Using data from the Monitored Atherosclerosis Regression Study, an angiographic trial of middle-aged men and women randomized to lovastatin or placebo, we investigated relationships between lipoprotein subclasses and progression of coronary artery atherosclerosis. Coronary artery lesion progression was determined by quantitative coronary angiography in low-grade (<50% diameter stenosis), high-grade (≥50% diameter stenosis), and all coronary artery lesions in 220 baseline/2-year angiogram pairs. Analytical ultracentrifugation was used to measure lipoprotein masses that were statistically evaluated for treatment group differences and relationships to progression of coronary artery atherosclerosis. All low density lipoprotein (LDL), intermediate density lipoprotein (IDL), and very low density lipoprotein (VLDL) masses were significantly lowered and all high density lipoprotein (HDL) masses were significantly raised with lovastatin therapy. The mass of smallest LDL (Svedberg flotation rate [S f ] 0 to 3), IDL (S f 12 to 20), all VLDL subclasses (S f 20 to 60, S f 60 to 100, and S f 100 to 400), and peak LDL flotation rate were significantly related to the progression of coronary artery lesions, specifically low-grade lesions. Greater baseline levels of HDL 3 were related to a lower likelihood of coronary artery lesion progression. In multivariate analyses, small VLDL (S f 20 to 60) and HDL 3 mass were the most important correlates of coronary artery lesion progression. These results provide further evidence for the importance of triglyceride-rich lipoproteins in the progression of coronary artery disease. In addition, these results present new evidence for the possible protective role of HDL 3 in the progression of coronary artery lesions. More specific information on coronary artery lesion progression may be obtained through the study of specific apolipoprotein B–containing lipoproteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.16.5.697

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 174

Metadata

Authors
Mack, W. J., Krauss, R. M., & Hodis, H. N.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
1996-05
Volume
16
Issue
5
Pages
697-704
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2159389024
Cited by
174
References
6
FWCI
14.59
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment Effects and Relation to Coronary Angiographic Progression. https://app.cochat.ai/papers/10.1161/01.atv.16.5.697
The paper
Mack, W. J., Krauss, R. M., & Hodis, H. N. (1996). Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment Effects and Relation to Coronary Angiographic Progression. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.16.5.697

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.